NCT00985660View on ClinicalTrials.gov

Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Healthy
Interventions
DRUG

Nisoldipine Extended-release Tablets, 30 mg

1 x 30 mg Tablet under fasting conditions

DRUG

Sular® Extended Release Tablets, 30 mg

1 x 30 mg Tablet under fasting conditions

Trial Locations (1)

58104

PRACS Institute Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY